NCT04089839View on ClinicalTrials.gov

A Study of Dasatinib Management Among CP-CML (Chronic Phase, Chronic Myeloid Leukemia) Participants Initiating Dasatinib in a Real Life Setting

CompletedOBSERVATIONAL
Enrollment

177

Participants

Timeline

Start Date

April 21, 2016

Primary Completion Date

January 16, 2020

Study Completion Date

January 16, 2020

Conditions
Chronic Myeloid Leukemia
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

75002

Local Institution, Paris

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY